Clinical experience with intrathecal bupivacaine in combination with opioid for the treatment of chronic pain related to failed back surgery syndrome and metastatic cancer pain of the spine

Spine Journal

Volumn 2, Issue 4, 2002, Pages 274-278

  Deer, Timothy R ^a,b   Caraway, David L ^c   Kim, Christopher K ^a   Dempsey, Connie Dee ^a   Stewart, C Douglas ^a   McNeil, Kenneth F ^a  

^a Center for Pain Relief   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c Center for Pain Relief   (United States)

Author keywords

Chronic pain; Efficacy; Intrathecal bupivacaine; Intrathecal morphine; Intrathecal pumps; Safety

Indexed keywords

AMIDE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BARBITURIC ACID DERIVATIVE; BUPIVACAINE; HYDROMORPHONE; LOCAL ANESTHETIC AGENT; MORPHINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; SPASMOLYTIC AGENT; TRAMADOL;

ADULT; AGED; ANALGESIA; ARTICLE; BACKACHE; CANCER PAIN; CANCER PATIENT; CHRONIC PAIN; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; EDEMA; FEMALE; HEALTH CARE UTILIZATION; HUMAN; INFUSION PUMP; INTRASPINAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METASTASIS; NEUROLOGICAL COMPLICATION; OUTCOMES RESEARCH; PAIN ASSESSMENT; PATIENT SATISFACTION; POSTOPERATIVE PAIN; RATING SCALE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SPINAL CORD TUMOR; SPINE; SPINE CANCER; SPINE DISEASE; SPINE METASTASIS; VISUAL ANALOG SCALE;

ADULT; AGED; ANALGESICS, OPIOID; ANESTHETICS, LOCAL; BACK PAIN; BUPIVACAINE; DRUG COMBINATIONS; FEMALE; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; MALE; MIDDLE AGED; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PATIENT SATISFACTION; RETROSPECTIVE STUDIES; SPINAL NEOPLASMS; SPINE;

EID: 0037043460     PISSN: 15299430     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1529-9430(02)00199-7     Document Type: Article

References (11)

1. Krames ES. Intraspinal opioid therapy for chronic nonmalignant pain: current practice and clinical guidelines. J Pain Sympt Manag 1996;11:333-52.
2. Li DF, Bahar M, Cole G, Rosen M. Neurological toxicity of the subarachnoid infusion of bupivacaine, lignocaine or 2-chloroprocaine in the rat. Br J Anaesth 1985;57: 424-9.
3. Ready L, Plumber M, Fink B, Sumi S. Intrathecal local anesthetic toxicity in rabbits. Anesthesiology 1983;59:A187.
4. Kroin JS, McCarthy RJ, Penn RD, Kerns JM, Ivankovich AD. The effect of chronic subarachnoid bupivacaine infusion in dogs. Anesthesiology 1987;66:737-42.
5. Burm A. Clinical pharmacokinetics of epidural and spinal anesthesia. Clin Pharmacokinet 1989;16:283-311.
6. Sjoberg M, Appelgren L, Einarsson S, et al. Long-term intrathecal morphine and bupivacaine in "refractory" cancer pain. I. Results from the first series of 52 patients. Acta Anaesthesiol Scand 1991;35: 30-43.
7. Nitescu P, Dahm P, Appelgren L, Curelaru I. Continuous infusion of opioid and bupivacaine by externalized intrathecal catheters in longterm treatment of "refractory" non-malignant pain. Clin J Pain 1998; 14 (1):17-28.
8. Krames ES, Lanning RM. Intrathecal infusional analgesia for nonmalignant pain: analgesic efficacy of intrathecal opioid with or without bupivacaine. J Pain Sympt Manag 1993;8:539-48.
9. Hildebrand KR, Elsberry, DD, Deer TR. Stability, compatibility and safety of intrathecal bupivacaine administered chronically via an implantable delivery system. Clin J Pain. In press.
10. Deer TR, Serafini M, Buchser E, Ferrante FM, Hassenbusch SJ. Intrathecal bupivacaine for chronic pain: a review of current knowledge. Neuromodulation. In press.
11. Hassenbusch S. Portenoy R. Current practices in intraspinal therapy: a survey of clinical trends and decision-making. J Pain Sympt Manag 2000;20:S4-11.